Disappointment over a cardiology board, an FDA approval, meeting news, and advice for practice—it’s all here this month.
For patients with ischemic stroke, tenecteplase seems to be a reasonable alternative to alteplase in terms of effectiveness and safety outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback